Correlation Between Swiftmerge Acquisition and LAVA Medtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Swiftmerge Acquisition and LAVA Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Swiftmerge Acquisition and LAVA Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Swiftmerge Acquisition Corp and LAVA Medtech Acquisition, you can compare the effects of market volatilities on Swiftmerge Acquisition and LAVA Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Swiftmerge Acquisition with a short position of LAVA Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Swiftmerge Acquisition and LAVA Medtech.

Diversification Opportunities for Swiftmerge Acquisition and LAVA Medtech

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Swiftmerge and LAVA is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Swiftmerge Acquisition Corp and LAVA Medtech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LAVA Medtech Acquisition and Swiftmerge Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Swiftmerge Acquisition Corp are associated (or correlated) with LAVA Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LAVA Medtech Acquisition has no effect on the direction of Swiftmerge Acquisition i.e., Swiftmerge Acquisition and LAVA Medtech go up and down completely randomly.

Pair Corralation between Swiftmerge Acquisition and LAVA Medtech

If you would invest  1,039  in Swiftmerge Acquisition Corp on August 26, 2024 and sell it today you would earn a total of  71.00  from holding Swiftmerge Acquisition Corp or generate 6.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy0.3%
ValuesDaily Returns

Swiftmerge Acquisition Corp  vs.  LAVA Medtech Acquisition

 Performance 
       Timeline  
Swiftmerge Acquisition 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Swiftmerge Acquisition Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Swiftmerge Acquisition is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
LAVA Medtech Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days LAVA Medtech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, LAVA Medtech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Swiftmerge Acquisition and LAVA Medtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Swiftmerge Acquisition and LAVA Medtech

The main advantage of trading using opposite Swiftmerge Acquisition and LAVA Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Swiftmerge Acquisition position performs unexpectedly, LAVA Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LAVA Medtech will offset losses from the drop in LAVA Medtech's long position.
The idea behind Swiftmerge Acquisition Corp and LAVA Medtech Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance